Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Sep 17, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenomeQuest said this week that CEO Ron Ranauro has resigned and will be replaced by Richard Resnick as acting CEO. Resnick will retain his role as VP of products and services at the company, a position he has held since 2008. He formerly was CEO of Mosaic Bioinformatics, and he was global bioinformatics software head at Wyeth. Before that, he was a member of Eric Lander's team at the Massachusetts Institute of Technology working on the Human Genome Project.

Complete Genomics has disclosed an additional member to its scientific advisory board and to its board of directors.

Larry Smarr, a member of the company's SAB, is the founding director of the California Institute for Telecommunications and Information Technology, and was the founding director of the National Center for Supercomputing Applications until 2000. From 1997 until 2005, he served on the advisory committee to the director of the National Institutes of Health.

Michael Rubin, who joined Complete's board of directors last month, is a financial analyst at Sands Capital Management, and was previously a resident physician in ophthalmology at the University of Chicago.

Thomas Caskey, chair of the board at Genome Canada, has been elected to the Division of Life Sciences of the Academy of Science of the Royal Society. Distinguished scholars are elected to the fellowship post annually.

Aushon BioSystems has appointed its scientific advisory board, including Johan de Bono, John Heymach, Gavin MacBeath, and Gordon Mills.

De Bono is a consultant in medical oncology at the Royal Marsden Hospital and Institute of Cancer Research. Heymach is an associate professor of Thoracic Head/Neck Medical Oncology and Cancer Biology at the University of Texas MD Anderson Cancer Center, and he is director of the Thoracic Blood Biomarker laboratory at the hospital.

MacBeath is senior director and head of translational research and co-founder at Merrimack Pharmaceuticals, and he was a faculty member in the Department of Chemistry and Chemical Biology at Harvard University.

Mills is Wiess distinguished university chair in Cancer Medicine, chair of the Department of Systems Biology in the Division of Cancer Medicine, and co-head of the Kleberg Center for Molecular Markers of the University of Texas MD Anderson Cancer Center.

Dara Corrigan has been appointed Associate Commissioner for Regulatory Affairs at the US Food and Drug Administration. Corrigan recently was associate deputy assistant secretary for health policy in the Office of the Assistant Secretary for Planning and Evaluation at the Department of Health and Human Services. She also formerly was a partner in the FDA and Health Care Policy Group at Arnold & Porter LLP.

WaferGen Biosystems has appointed Donald Huffman to serve as its chief financial officer. Huffman recently was CFO at Asante Solutions and before that he was CFO at Guava Technologies.

"[Huffman] has been a key participant in structuring and negotiating approximately $650 million in merger acquisitions and spinout transactions and has relevant experience in the genomics and medical device arenas, having served as an executive at companies with products in both," WaferGen CEO and Chairman Alnoor Shivji said in a statement.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.